BryceAndrewKerlinMD

Pediatric Hematology & Oncology • Columbus, OH

Pediatric Coagulation Disorder Hematology, Pediatric Platelet Disorder Hematology

Professor of Pediatrics, Ohio State University

Join to view full profile

Dr. Kerlin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kerlin's full profile

Already have an account?

Office
700 Childrens Dr
Columbus, OH 43205
Phone+1 614-722-3552

Fax+1 614-722-3699

Education & Training

Medical College of Wisconsin Affiliated HospitalsFellowship, Pediatric Hematology/Oncology, 1999 - 2002
Phoenix Children's HospitalResidency, Pediatrics, 1996 - 1999
Medical College of WisconsinClass of 1996

Certifications & Licensure

OH State Medical License 2004 - 2026
WI State Medical License 1999 - 2013
CA State Medical License 2002 - 2006
AZ State Medical License 1998 - 2000
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

HTRS TE Registry (ThromboEmbolism Registry) Start of enrollment: 2005 Dec 01
Completed

Publications & Presentations

PubMed

2 citations
Reciprocal stabilization of coagulation factor XIII-A and -B subunits is a determinant of plasma FXIII concentration.
James R Byrnes, Taek Lee, Sherif Sharaby, Robert A Campbell, Dre'Von A Dobson
Blood. 2024-02-01
213 citations
Epidemiology and Pathophysiology of Nephrotic Syndrome–Associated Thromboembolic Disease
Bryce A. Kerlin, William E. Smoyer
Clinical Journal of the American Society of Nephrology. 2012-03-01
30 citations
Role of direct oral anticoagulants in patients with kidney disease
Vimal K. Derebail, Michelle N. Rheault, Bryce A. Kerlin
Kidney International. 2020-04-01

Lectures

A Novel Enzyme Capture – ELISA for the Direct Determination of Factor XIII Activity
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
The Hypofibrinolytic Defect of Nephrotic Syndrome Is Directly Proportional to Fibrin Network Density
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

New Targets for Nephrotic Syndrome Treatment?September 10th, 2017